• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (25)
    • Drug Repositioning
    • Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression.
    • Hysteria
    • Cognitive Dysfunction
    • GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
    • See All 25 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.

View in: PubMed

subject areas
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Apolipoproteins E
  • Case-Control Studies
  • Chromosomes, Human, Pair 3
  • Chromosomes, Human, Pair 6
  • DNA-Binding Proteins
  • Female
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Male
  • Membrane Glycoproteins
  • Middle Aged
  • Muscle Proteins
  • Peptide Fragments
  • Phenotype
  • Phosphorylation
  • Polymorphism, Single Nucleotide
  • Receptors, Immunologic
  • Repressor Proteins
  • Risk Factors
  • Serine
  • tau Proteins
  • Trans-Activators
  • Transcription Factors

authors with profiles
  • Steven L. Carroll